Add BrightSurf on Google Email

Search results for “Microbiology”

1,000+ results for "Microbiology"

Turning a poison into food

Researchers at the Max Planck Institute for Marine Microbiology reveal how a specific enzyme, Fsr, converts sulfite into sulfide, allowing methanogens to grow safely on toxic substances. This discovery opens opportunities for biotechnological applications and provides insights into the evolution of these microorganisms.

SourceMax Planck Institute for Marine Microbiology·JournalNature Chemical Biology·DateJan 19, 2023

Slime for the climate, delivered by brown algae

Researchers discovered that brown algae's fucoidan can remove large amounts of carbon dioxide from the global cycle in the long term. The fucoidan is a recalcitrant molecule that does not return to the atmosphere quickly, making the brown algae particularly effective in removing carbon dioxide from the atmosphere.

SourceMax Planck Institute for Marine Microbiology·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 26, 2022

Oil-based systems show promise for eradicating salmonella on food production machinery

A new study published in Applied and Environmental Microbiology suggests that oil formulations with food-grade organic acids can kill dried Salmonella on stainless steel surfaces. This approach has the potential to replace water-based cleaning methods, which promote microbial growth and are often challenging to use.

SourceAmerican Society for Microbiology·JournalApplied and Environmental Microbiology·TypeExperimental study·DateAug 8, 2022

Longest known COVID-19 infection – 505 days – described by UK researchers

Researchers from King's College London and Guy's and St Thomas' NHS Foundation Trust studied nine immunocompromised patients with persistent COVID-19 infections, finding that five developed at least one mutation seen in variants of concern. The study provides evidence that new variants may develop in immunocompromised individuals.

People at risk of future heart disease and stroke may be at greater risk for severe COVID-19

A study of nearly a million adults in England found that those at risk of heart attack or stroke over the next 10 years are substantially more likely to become seriously unwell with COVID-19. People with elevated cardiovascular risk were six times as likely to die from COVID-19 and had three times the risk of hospitalization, according...

Both antibiotic resistant bacteria and genes transmitted between healthy dogs and cats and their owners, finds study in UK and Portugal

Researchers found that healthy companion animals and their owners can transmit antibiotic-resistant bacteria and genes to each other, highlighting the importance of hygiene practices around pets. The study suggests that even low-level shedding of bacteria by healthy carriers can pose a risk to vulnerable individuals.

New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy

New data from the MOVe-OUT trial reveals that molnupiravir significantly reduces SARS-CoV-2 infection within three days of treatment. In contrast, those receiving a placebo took up to five days to clear the virus. The study confirms molnupiravir's effectiveness in accelerating viral RNA decline and eliminating infectious virus.

New analysis of investigational COVID antiviral drug molnupiravir shows it appears to clear virus equally well in immunocompromised patients and those who are immunocompetent

A new analysis of data on molnupiravir shows the drug effectively clears active SARS-CoV-2 virus in both immunocompromised and non-immunocompromised patients. The study found similar reductions in viral replication and no infectious virus detected after treatment, indicating equal efficacy in both groups.

Evidence is currently insufficient to show omicron variant has a shorter period of infectiousness compared with previous variants

The omicron variant's infectiousness period is uncertain, with evidence suggesting it may not be shorter than previous variants. Dr Marjolein Irwin-Knoester recommends a maximum of 7-day isolation for most cases, striking a balance between virus infectivity and community acceptance.

Evidence continues to build that organ donation from people dying after a positive COVID-19 test is safe and does not transmit SARS-CoV-2 to the recipient

The European Society of Clinical Microbiology and Infectious Diseases finds organ donation from COVID-19 patients is safe and does not transmit SARS-CoV-2. Recipients with asymptomatic infections are also now eligible for transplant, but must be triple-vaccinated.

Early study shows that organ donation from dying patients that have tested positive for COVID-19 is safe and does not infect recipients with SARS-CoV-2

Organ donation from dying COVID-19 patients appears to be safe and does not infect recipients with SARS-CoV-2. The study found all 6 abdominal organs had stable graft function and no unexpected rejection occurred.

SourceEuropean Society of Clinical Microbiology and Infectious Diseases·JournalClinical Microbiology and Infection·DateMar 22, 2022

Study finds previous COVID-19 infection, but not vaccination, improves performance of antibodies and potentially provides longer-term protection

A study found that previous COVID-19 infection improves the performance of antibodies and potentially provides longer-term protection, especially in obese individuals. In contrast, vaccination does not enhance antibody quality and may not provide sustained immunity in those who have been previously infected or overweight.

Oregon State microbiology research furthers understanding of ocean’s role in carbon cycling

The study tracks ocean microbes consuming different types of organic carbon produced by phytoplankton species, revealing predictable food source preferences. The findings have implications for understanding marine microbes and photosynthetic algae's impact on global carbon cycling.

SourceOregon State University·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateOct 7, 2021